Brief: Delcath Systems Announces FDA Acceptance Of NDA Resubmission Of Hepzato Kit

Delcath Systems

27/03/2023 13:27

March 27 (Reuters) - Delcath Systems Inc  DCTH.O :
    * DELCATH SYSTEMS, INC. ANNOUNCES FDA ACCEPTANCE OF NEW DRUG
APPLICATION RESUBMISSION OF HEPZATO KIT WITH A PDUFA DATE OF
AUGUST 14, 2023

Source text for Eikon:  ID:nPn9ZHJQga 
Further company coverage:  DCTH.O 

 ((Reuters.Briefs@thomsonreuters.com;))